Shanghai Pharmaceuticals (601607.SH): Cefuroxime Sodium for Injection and Amoxicillin Sodium for Injection Passed Generic Drug Consistency Evaluation.

Zhongtong Finance APP News, Shanghai Pharmaceuticals (601607.SH) announced that recently, its subsidiary Shanghai Shanghai Pharmaceuticals New Asia Pharmaceutical Co., Ltd. (hereinafter referred to as "Shanghai New Asia") received the "Drug Supplement Application Approval Notice" (Notice No.: 2025B05069, 2025B05110, 2025B05111) issued by the National Medical Products Administration for the injection cephalosporin sodium and the injection cefamoside. These drugs have passed the evaluation of generic drug quality and efficacy consistency.